About
Precision medicine is akin to "taking the first steps on a thousand-mile journey", it being possible not without collaboration of experts on a worldwide basis. In the light of the above, China-US Precision Medicine Summit – with a theme of "Transforming lives through pioneering Precision Medicine" – was successfully unveiled on March 29, 2018 in Beijing. The Summit features participants from government authorities, enterprises, academic circles and clinical practices, making it an unparalleled platform for exchanges among players throughout the industry chain as well as among those in China and U.S. Its aim is to foster dialog between Chinese and American governments, explore the international management framework for precision medicine, provide guidance for collaboration between the government, enterprises and academia, focus on latest technologies and promotion of precision medicine using digital technology, and forecast precision treatment and management of diseases.
Hosts
CEO Roundtable on Cancer
China Academy of Medical Sciences (CAMS)
Peking Union Medical College (PUMC)
Honorary Hosts
Embassy of the United States, Beijing
The US-China Business Council (USCBC)
Sponsor
Thermo Fisher Scientific
Speakers
Dr. Martin J. Murphy
Chief Executive Officer CEO Roundtable on Cancer
Dr. WANG Chen
President, China Academy of Medical Sciences and Peking Union Medical College
Mark Stevenson
Executive Vice President and Chief Operating Officer Thermo Fisher Scientific
Dr. Douglas Lowy
Deputy Director National Cancer Institute
Prof. LI Jin
President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University
Dr. WANG Yu
Former Director General Chinese Center for Disease Control and Prevention
Prof. ZHAN Qimin
President, Peking University Health Science Center (PKUHSC) Vice President, Peking University
Tony Acciarito
President Thermo Fisher Scientific China
Dr. Steffan Ho
Vice President and Head of Translational Oncology Group Pfizer
Dr. Corina Shtir
Head of Precision Medicine Thermo Fisher Scientific
Dr. Joseph Eid
Global Head of Medical Affairs Bristol Myers Squibb (BMS)
Dr. Matthew D. Brown
Director, China Office, Center for Global Health, National Cancer Institute, National Institutes of Health
Prof. LIU Yuanli
Dean, School of Public Health China Academy of Medical Sciences and Peking Union Medical College
Prof. DONG Zigang
Executive Director, The Hormel Institute, University of Minnesota, McKnight Presidential Professor of Cancer Prevention, Hormel/Knowlton Professor, I. J. Holton Professor
Prof. QIAO Jie
President, Peking University Third Hospital Academician of China Academy of Engineering
Prof. LIAO Can
President, Guangzhou Women and Children’s Medical Center
Prof. QIN Jun
Director, National Center for Protein Science Beijing
Prof. Bruce Ling
Director, Translational Medicine Stanford University
Dr. Todd Hembrough
President, Proteomics NantOmics, LLC
William Liang
Vice President, Head of China Oncology AstraZeneca
Prof. Andrew Kasarskis
Director, Icahn Institute for Genomics and Multiscale Biology
Prof. Catherine Wong
Director of Precision Medicine Multi-Omics Center, Peking University Health Science Center
Dr. CAI Long
President, National Health and Medicine Big Data (Nanjing) Center
Prof. Nam Do Hyun
Director of Samsung Institute of Refractory Cancer
Prof. Timothy Triche
Prof. Timothy Triche Professor, Pathology and Pediatrics, Keck School of Medicine at USC and Co-Director, Center for Personalized Medicine, Childrens, Hospital Los Angeles (CHLA)
Prof. ZHAO Yangbing
Director, T Cell Engineering Laboratory, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine
Prof. QIAO Youlin
Director for Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College
Dr. Alan Sachs
Chief Scientific Officer Thermo Fisher Scientific
Prof. LI Yixue
Director, Shanghai Center for Bioinformation Technology
Dr. YANG Hongwei
Former Deputy Director China National Health Development Research Center
Dr. Frank Su
Founding Partner of Redhill Capital
Dr. Seth Sadis
Director, Oncology Informatics and Software Clinical Sequencing Division Thermo Fisher Scientific
Dr. Martin J. Murphy
Chief Executive Officer CEO Roundtable on Cancer
Dr. WANG Chen
President, China Academy of Medical Sciences and Peking Union Medical College
Mark Stevenson
Executive Vice President and Chief Operating Officer Thermo Fisher Scientific
Dr. Douglas Lowy
Deputy Director National Cancer Institute
Prof. LI Jin
President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University
Dr. WANG Yu
Former Director General Chinese Center for Disease Control and Prevention
Prof. ZHAN Qimin
President, Peking University Health Science Center (PKUHSC) Vice President, Peking University
Tony Acciarito
President Thermo Fisher Scientific China
Agenda
March 29, China-US Precision Medicine Summit
* Agenda will be updated with latest attendances
8:00 a.m. – 8:50 a.m.
Sign up, Opening remarks
Session One：
Ending Cancer needs Sino-U.S. Collaboration with Precision Medicine
8:50 a.m. - 10:10 a.m.
Keynote speech: Preventing Cervical Cancer in China, the United States, and Globally
Dr. Douglas Lowy Deputy Director, National Cancer Institute
Keynote Speech: Research and Development of a Precise Anti-Cancer Drug - Our Experience and Strategy
Prof. LI Jin President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University
Panel discussion: International framework on Precision Medicine with outstanding contribution from China and U.S.
Session Two: Accelerating Precision Medicine – Roles and Responsibilities of Industry, Academia and the Clinic
10:40 a.m. - 5:35 p.m.
Keynote Speech: The Future of Precision Medicine on Cancer Research in China
Prof. ZHAN Qimin President, Peking University Health Science Center (PKUHSC)
Vice President, Peking University
Keynote speech: Value of Dynamic Precision Medicine Eco System for a Healthier China
Tony Acciarito President, Thermo Fisher Scientific China
Keynote speech: Transform the oncology research to real clinical benefit for patients experience from industry
Dr. Steffan Ho Vice President and Head of the Translational Oncology group at Pfizer
Panel discussion: Looking Towards a World Without Cancer
Keynote speech: Single Cell Genomics: MALBAC in Reproductive Health and Inherited Disease
Prof. QIAO Jie President, Peking University Third Hospital, Academician of China Academy of Engineering
Keynote speech: Metagenomics - Reproductive Health and Inherited Disease
Prof. LIAO Can President, Guangzhou Women and Children’s Medical Center
Keynote speech: Oncology: Biomarker selection in cancer diagnosis & therapy
Prof. Jun Qin Director, National Center for Protein Science Beijing
Panel discussion: Technical advances shaping precision medicine
Keynote speech: Precise Diagnosis and Treatment of Pediatric Cancer: Real World Experience at Childrens Hospital Los Angeles
Prof. Timothy Triche Professor, Pathology and Pediatrics, Keck School of Medicine at USC and Co-Director, Center for Personalized Medicine, Childrens, Hospital Los Angeles (CHLA)
Keynote speech: Promise of CAR T-Cell Therapy for the Treatment of Cancer
Prof. Yangbing Zhao Director, T Cell Engineering Laboratory, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine
Panel discussion :Impact of Digital Health for Precision Medicine
Keynote Speech: Precise Prevention of Cervical Cancer and HPV Vaccination in China
Prof. QIAO Youlin Director for Department of Cancer Epidemiology, Cancer Institute,
Chinese Academy of Medical Sciences and Peking Union Medical College
Panel discussion: Impact of Digital Health for Precision Medicine
Park Hyatt Beijing( 2 JianGuoMenWai Street, Chaoyang District)
For questions about the summit, please contact:
Effie Xiang
Email: Effie.xiang@thermofisher.com
Phone: +86 139 1615 4531
About
Precision medicine is akin to "taking the first steps on a thousand-mile journey", it being possible not without collaboration of experts on a worldwide basis. In the light of the above, China-US Precision Medicine Summit – with a theme of "Transforming lives through pioneering Precision Medicine" – was successfully unveiled on March 29, 2018 in Beijing. The Summit features participants from government authorities, enterprises, academic circles and clinical practices, making it an unparalleled platform for exchanges among players throughout the industry chain as well as among those in China and U.S. Its aim is to foster dialog between Chinese and American governments, explore the international management framework for precision medicine, provide guidance for collaboration between the government, enterprises and academia, focus on latest technologies and promotion of precision medicine using digital technology, and forecast precision treatment and management of diseases.
Hosts
China Academy of Medical Sciences (CAMS)
Peking Union Medical College (PUMC)
CEO Roundtable on Cancer
Honorary Hosts
Embassy of the United States, Beijing
The US-China Business Council (USCBC)
Sponsor
Thermo Fisher Scientific
Speakers
Agenda
8:00 a.m. – 8:50 a.m.
Sign up, Opening remarks
Session One：
Ending Cancer needs Sino-U.S. Collaboration with Precision Medicine
8:50 a.m. - 10:10 a.m.
Keynote speech: Preventing Cervical Cancer in China, the United States, and Globally
Dr. Douglas Lowy Deputy Director, National Cancer Institute
Keynote Speech: Research and Development of a Precise Anti-Cancer Drug - Our Experience and Strategy
Prof. LI Jin President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University
Panel discussion :International framework on Precision Medicine with outstanding contribution from China and U.S.
Session Two: Accelerating Precision Medicine – Roles and Responsibilities of Industry, Academia and the Clinic
10:40 a.m. - 5:35 p.m.
Keynote Speech: The Future of Precision Medicine on Cancer Research in China
Prof. ZHAN Qimin President, Peking University Health Science Center (PKUHSC)
Vice President, Peking University
Keynote speech: Value of Dynamic Precision Medicine Eco System for a Healthier China
Tony Acciarito President, Thermo Fisher Scientific China
Keynote speech: Transform the oncology research to real clinical benefit for patients experience from industry
Dr. Steffan Ho Vice President and Head of the Translational Oncology group at Pfizer
Panel discussion : Looking Towards a World Without Cancer
Keynote speech: Single Cell Genomics: MALBAC in Reproductive Health and Inherited Disease
Prof. QIAO Jie President, Peking University Third Hospital, Academician of China Academy of Engineering
Keynote speech: Metagenomics - Reproductive Health and Inherited Disease
Prof. LIAO Can President, Guangzhou Women and Children’s Medical Center
Keynote speech: Oncology: Biomarker selection in cancer diagnosis & therapy
Prof. Jun Qin Director, National Center for Protein Science Beijing
Panel discussion : Technical advances shaping precision medicine
Keynote speech: Precise Diagnosis and Treatment of Pediatric Cancer: Real World Experience at Childrens Hospital Los Angeles
Dr. Timothy Triche Professor, Pathology and Pediatrics, Keck School of Medicine at
USC and Co-Director, Center for Personalized Medicine, Childrens, Hospital Los Angeles (CHLA)
Keynote speech: Promise of CAR T-Cell Therapy for the Treatment of Cancer
Prof. Yangbing Zhao Director, T Cell Engineering Laboratory, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine
Panel discussion :Impact of Digital Health for Precision Medicine
Keynote Speech: Precise Prevention of Cervical Cancer and HPV Vaccination in China
Prof. QIAO Youlin Director for Department of Cancer Epidemiology, Cancer Institute,
Chinese Academy of Medical Sciences and Peking Union Medical College
Panel discussion: Impact of Digital Health for Precision Medicine
Park Hyatt Beijing( 2 JianGuoMenWai Street, Chaoyang District)
For questions about the summit, please contact:
Effie Xiang
Email: Effie.xiang@thermofisher.com
Phone: +86 139 1615 4531